PT-141 Driada Medical 10mg

PT-141 10mg

Bremelanotide, also known as PT-141, is a compound developed for the treatment of female sexual dysfunction, hemorrhagic shock, and reperfusion injury. It activates melanocortin receptors in the central nervous system, modulating inflammation and limiting ischemia. Initially studied for intranasal use in female sexual dysfunction, development for this use was temporarily halted due to adverse effects on blood pressure. Subsequent studies explored subcutaneous injection, with minimal effects on blood pressure.

Bremelanotide is derived from the peptide hormone Melanotan 2, which has been studied for tanning without sun exposure. Melanotan 2 has been found to induce sexual arousal and spontaneous erections. Bremelanotide has been shown to be effective in treating sexual dysfunction in both men (erectile dysfunction) and women (sexual arousal disorder) by directly increasing sexual desire through its effects on the nervous system.

Action mechanism

Bremelanotide is an alpha-melanocyte-stimulating hormone (alpha-MSH) analogue that activates melanocortin receptors in the central nervous system. Its centrally mediated activity makes it potentially useful in the treatment of erectile dysfunction, decreased sexual motivation, and loss of libido.

Bremelanotide, or PT-141, is a potent erection initiator with minimal side effects, a rapid onset of action, and a relatively long duration. Recent studies confirm improved erectile response with sexual stimulation. It can act independently or synergistically with PDE-5 inhibitors such as Viagra or Cialis, offering an alternative therapy for organic and psychogenic erectile dysfunction.

Effects

• Promotes sexual desire and erection

Side effects

• Nausea
• Facial redness
• Heachache

Use

• The first erection occurs approximately 30 minutes after administration. Peak blood concentrations are reached within 60 minutes and gradually decline over the course of 4 hours.
• It can be used in combination with other drugs such as sildenafil and tadalafil to achieve enhanced effects.

Preparing the solution

To prepare a solution for injection, take a syringe with a diluent and inject it into a vial containing the lyophilized powder. Tilt the vial so that the needle touches the wall, allowing the diluent to flow slowly. Stir gently until the powder has dissolved and the solution is clear. Avoid mixing peptides in the same syringe.

Conservation

• The solution can be stored in the refrigerator at 2 to 8 degrees Celsius for approximately 21 days. If using bacteriostatic water, the shelf life may be longer.